NEW YORK – Global law firm Reed Smith today announced that it has advised Velocity Clinical Research, Inc., a portfolio company of firm client GHO Capital Partners, in connection with Velocity’s add-on acquisition of NRI Clinical Research, LLC.
Velocity is an Owned Site Organization, dedicated to providing excellence in patient care, high quality data and fully integrated research sites. It serves biopharmaceutical and contract research organization clients in primarily conducting Phase II and Phase III clinical trials in support of their global drug development programs.
NRI provides trial participants access to innovative therapies through Phase I-IV Clinical trials.
GHO Capital Partners is a global asset manager focused exclusively on the life sciences and healthcare sector.
The private equity team advising Velocity was led by New York corporate partners Mark Pedretti and Seth Merl.
A copy of the press release issued Velocity can be found on PR Newswire.